Foster Dykema Cabot & Partners, LLC Prokidney Corp Ord Shs Cl A(Cy Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 54 shares of PROK stock, worth $91. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54Holding current value
$91% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PROK
# of Institutions
77Shares Held
46.2MCall Options Held
505KPut Options Held
127K-
Morgan Stanley New York, NY14.3MShares$24.1 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY12.3MShares$20.9 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.22MShares$8.81 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$6.18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$3.72 Million0.0% of portfolio
About PROKIDNEY CORP ORD SHS CL A(CY
- Ticker PROK
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,540,200
- Market Cap $104M